Anebulo Pharmaceuticals, Inc. (15)
Browse by Contract Category
Contracts
-
Employment Agreement, effective as of May 20, 2022, between Anebulo Pharmaceuticals, Inc. and Kenneth Cundy
(Filed With SEC on May 24, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on April 26, 2021)
-
Right of First Refusal and Co-Sale Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP
(Filed With SEC on April 1, 2021)
-
License Agreement, dated May 26, 2020, between Vernalis (R&D) Limited and Anebulo Pharmaceuticals, Inc
(Filed With SEC on April 1, 2021)
-
Form of Indemnification Agreement between Anebulo Pharmaceuticals, Inc. and each of its directors
(Filed With SEC on April 1, 2021)
-
Employment Agreement, effective as of February 1, 2022, between Anebulo Pharmaceuticals, Inc. and Simon Allen
(Filed With SEC on January 5, 2022)
-
Specimen Stock Certificate for Common Stock
(Filed With SEC on April 1, 2021)
-
Warrant to Purchase Shares of Preferred Stock, dated as of March 8, 2021, between Anebulo Pharmaceuticals, Inc. and Aron English
(Filed With SEC on April 1, 2021)
-
Warrant to Purchase Shares of Preferred Stock, dated as of March 8, 2021, between Anebulo Pharmaceuticals, Inc. and 22NW, LP
(Filed With SEC on April 1, 2021)
-
Series A Preferred Stock Purchase Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP
(Filed With SEC on April 1, 2021)
-
Investors Rights Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP
(Filed With SEC on April 1, 2021)
-
Employment Agreement, dated July 21, 2020, between Daniel Schneeberger and Anebulo Pharmaceuticals, Inc
(Filed With SEC on April 1, 2021)
-
Amendment No. 1 to Employment Agreement, dated January 22, 2021, between Daniel Schneeberger and Anebulo Pharmaceuticals, Inc
(Filed With SEC on April 1, 2021)
-
Anebulo Pharmaceuticals, Inc. 2020 Stock Incentive Plan, and Form of Award Agreement thereunder
(Filed With SEC on April 1, 2021)
-
Consultancy Agreement, dated July 15, 2020, between Anebulo Pharmaceuticals, Inc. and Traxeus Pharma Services Limited
(Filed With SEC on April 1, 2021)